#DGCI&S

[newsorbiter]

India’s exports of final food products register impressive growth

The country’s exports of Ready to Eat (RTE), Ready to Serve (RTS) and Ready to Cook (RTC) foods under Agriculture and Processed Food Products Export Development Authority (APEDA)  basket have exceeded USD 2 billion  during 2020-21. India exports RTE food products majorly to USA, UAE, Nepal, Canada, Sri Lanka, Australia, Sudan, UK, Nigeria and Singapore. Meanwhile, the Ministry of Commerce and Industry has laid thrust on value addition of these products for exports which include biscuits, confectionery, breakfast cereals, Indian sweets and snacks among others. The food products under the RTE category have registered CAGR of 12 per cent in the last 10 years. The demand for RTE, RTC and RTS food items has increased significantly raising their export by more than 23% during April to October 2021-22. According to the data provided by the Directorate General of Commercial Intelligence and Statistics(DGCI&S), Kolkata, the country exported these products worth USD 5,438 million from 2018-19 to 2020-21. Especially export in the RTS food category has been USD 511 million in 2020-21. The growth rate of RTE products in 2020-21 against previous year was 26% and these products were exported to the top 10 countries. On the other hand, the RTC food products have achieved the growth rate of 7 per cent in last one decade. The two countries-- UK and Indonesia are at the top for importing powder, starch and papad during 2020-21. The RTC products of India are being exported majorly to USA, UA Read the full article

[nasiknews]

India's agricultural, processed food products exports up by 31%

India’s agricultural, processed food products exports up by 31%

Exports of agricultural and processed food products rose by 31 per cent in the first three months of the current financial Year 2022-23 (April-June) in comparison to the corresponding period of FY 2021-22, as per government data. As per the provisional data released by the Directorate General of Commercial Intelligence and Statistics (DGCI&S), the overall export of the Agricultural and Processed…

[zstvnews]

માંસ, ચોખા, ઘઉં, ખાંડની અત્યાર સુધીની સૌથી વધુ નિકાસ થઈ: સરકાર

માંસ, ચોખા, ઘઉં, ખાંડની અત્યાર સુધીની સૌથી વધુ નિકાસ થઈ: સરકાર

ભારત સરકારે જણાવ્યું હતું કે, વર્ષ 2021-22 માટે કૃષિ ઉત્પાદનો (દરિયાઈ અને વાવેતર ઉત્પાદનો સહિત)ની નિકાસ USD 50 બિલિયનને વટાવી ગઈ છે, જે કૃષિ ���િકાસ માટે અત્યાર સુધીનું સર્વોચ્ચ સ્તર છે. DGCI&S દ્વારા બહાર પાડવામાં આવેલા કામચલાઉ આંકડાઓ મુજબ, 2021-22 દરમિયાન કૃષિ નિકાસ 19.92% વધીને $50.21 બિલિયનને સ્પર્શી ગઈ છે. વૃદ્ધિ દર નોંધપાત્ર છે કારણ કે તે 2020-21માં હાંસલ કરેલી 17.66% ની વૃદ્ધિ કરતાં વધુ અને…

[sachkiawaaj]

Covaxin gets DGCI`s approval for use among children above 12 years with certain conditions

Covaxin gets DGCI`s approval for use among children above 12 years with certain conditions

New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech’s Covaxin for children above 12 years with certain conditions, official said on Saturday (December 25). It is the second vaccine to receive the regulator’s nod for use among those below 18 years after Zydus Cadila’s needle-free COVID-19 vaccine ZyCoV-D. The…

[captainrtsprofessionalstudies]

Export Turnover

Ministry of Commerce & Industry   Export Turnover Posted On: 08 DEC 2021 6:28PM by PIB Delhi India’s merchandise export during last three years and current year are as follows: Years Value of Merchandise export (US$ Billion) 2018-19 330.08 2019-20 313.36 2020-21 291.81 2020-21 (Apr-Nov) 174.46 2021-22 (Apr-Nov)* 263.42 Source: DGCI&S. * Provisional The accumulated amount of payments on…

[bbcbreakingnews]

Covishield jab takes 4 minutes, Covaxin double that time

MUMBAI: If it takes around four minutes to check the documents and administer the Covishield vaccine, it takes double the time for the Covaxin vaccine. The time associated with Covaxin vaccine is longer because the recipient, unlike the takers of the Covishield vaccine, has to sign a consent form as per the requirement of its Drug Controller General of India (DGCI) clearance. “Also, readings of the recipient’s blood pressure, temperature and oxygen saturation have to be taken,” said Dr Ranjit Mankeshwar, acting dean of state-run JJ Hospital, Byculla. JJ Hospital is one of the six centres where the Covaxin is available. The recipient of the Covaxin vaccine is also asked a series of questions, such as contact with people who travelled. “A three-page document is given to the recipient in which they has to select an option if they develop any symptoms over the next seven days,” said a doctor. The document has to be later handed over to the vaccinators. Recipients for the Serum Institute of India’s Covishield vaccine, on the other hand, are not asked any questions. Only their identity proof is verified. Many doctors, however, advise people to consult their family physician for a thorough evaluation of any possible allergic reaction. All vaccine recipients have to wait for 30 minutes after the vaccination for observation. Dr S Nikam, the civil surgeon at Amravati district hospital, said that it takes a minimum of 40 minutes — including 10 minutes for the pre-vaccine work and the vaccine — for each recipient getting the Covaxin. Covishield and Covaxin are different types of vaccines. While Covaxin is made from an inactivated or dead virus, Covishield uses a replication-deficient chimpanzee viral vector that is a weakened version of a common cold virus (adenovirus). “Covaxin is safe because it is based on an inactivated virus and has very low to zero side-effects,” said state department of medical education’s chief Dr T P Lahane.

source https://bbcbreakingnews.com/2021/01/19/covishield-jab-takes-4-minutes-covaxin-double-that-time/

[darshan-bioinformatics]

COVISHIELD VACCINE

                                     COVISHIELD VACCINE

COVID-19 disease is caused by a coronavirus called SARS-CoV-2. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. Covishield, along with Bharat Biotech’s Covaxin, were approved for restricted emergency use by the Drugs Controller General of India (DGCI) on January 3 (Sunday). Covishield is manufactured and marketed by Serum Institute of India in Pune. Covishield is developed by Oxford-AstraZeneca in collaboration with Serum Institute of India,Pune.

Covishield vaccine includes the following ingredients: L-Histidine, L-Histidine hydrochloride monohydrate, Magnesium chloride hexahydrate, Polysorbate 80, Ethanol, Sucrose, Sodium chloride, Disodium edetate dihydrate (EDTA), Water for injection. The AstraZeneca (COVISHIELD) COVID-19 (AZD1222) coronavirus vaccine candidate, formerly known as ChAdOx1 nCoV-19, is made from a virus (ChAdOx1), a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees, that has been genetically changed so that it can't grow in humans.

Genetic material has been added to the ChAdOx1 construct, which is used to make proteins from the SARS-CoV-2 coronavirus called Spike glycoprotein (S). This protein is usually found on the surface of SARS-CoV-2 and plays an essential role in the infection pathway of the SARS-CoV-2 virus.The SARS-CoV-2 coronavirus uses its spike protein to bind to ACE2 receptors on human cells to enter the cells and cause an infection. After vaccination, the surface spike protein is produced, priming the immune system to attack the coronavirus if it later infects the body and causes COVID-19 disease

By vaccinating with AZD1222 (ChAdOx1 nCoV-19), these researchers hope to make the body recognize and develop an immune response to the Spike protein to help stop the SARS-CoV-2 virus from entering human cells and therefore prevent infection. The dose will be given to an individual as an intramuscular (IM) injection, ideally on the deltoid muscle and the vaccination course comprises two separate doses of 0.5 millilitres (ml) each, according to SII. If you receive one dose of the Covishield vaccine, then the second dose should be administered between 4 to 6 weeks after the first dose. The first 100 million doses of the vaccine has been provided to the government at the cost of ₹200 per dose, with SII’s chief executive officer (CEO) and owner Adar Poonawalla adding that the cost will increase later on.

Prime Minister Narendra Modi launched India’s Covid-19 vaccination drive, the world’s largest inoculation exercise against the novel coronavirus on 16th of January,2021. As India began its nationwide vaccination drive against Covid-19, as many as 1,65,714 people were vaccinated on Day 1, Union Health Ministry said.

References:

https://www.news18.com/news/buzz/how-oxford-scientists-developed-astrazenecas-covishield-vaccine-in-record-time-3291593.html

https://www.nature.com/articles/s41586-020-2608-y

https://www.livemint.com/science/health/covid19-an-faq-factsheet-for-covishield-vaccine-by-serum-institute-11610496726579.html

[nasiknews]

India's agricultural, processed food products exports up by 31%

India’s agricultural, processed food products exports up by 31%

Exports of agricultural and processed food products rose by 31 per cent in the first three months of the current financial Year 2022-23 (April-June) in comparison to the corresponding period of FY 2021-22, as per government data. As per the provisional data released by the Directorate General of Commercial Intelligence and Statistics (DGCI&S), the overall export of the Agricultural and Processed…

[swedna]

Shares of Biocon surged 10 per cent to Rs 455, also its new high, on the BSE on Monday after the company said it has received the approval of Drugs Controller General of India (DCGI) to market its novel biologic drug Itolizumab for treatment of patients with moderate to severe Covid-19 complications. The stock opened 10 per cent higher on the BSE and 8 per cent higher at Rs 447 on the National Stock Exchange (NSE).

“Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe Covid-19 complications. Biocon has repurposed Itolizumab, an anti-CD6 IgG1 monoclonal antibody launched in India in 2013 as ALZUMAb for treating chronic plaque psoriasis, for the treatment of CRS in moderate to severe ARDS patients due to COVID-19,” Biocon said in a press release.

Itolizumab will be manufactured and formulated as an intravenous injection at Biocon’s bio-manufacturing facility at Biocon Park, Bengaluru, it said.

“This positions India amongst the leading global innovators in their effort to overcome the Covid-19 pandemic. The randomized control trial indicated that all the patients treated with Itolizumab responded positively and recovered. We plan to take this therapy to other parts of the world impacted by the pandemic,” said the company's Executive Chairperson, Kiran Mazumdar-Shaw.

However, in a note, ICICI Securities said, "The company is likely to garner temporary finite opportunity from this drug. We do not expect significant financial benefit from this approval."

At 09:23 am, the stock had partially erased its early morning gain and was trading 3 per cent higher at Rs 428 on the BSE. In comparison, the S&P BSE Sensex was up 0.89 per cent at 36,921 points. A combined 4.6 million equity shares have changed hands on the counter on the NSE and BSE so far.

[diademy-blog]

What is FDC Stands For?

 Fixed-Dose Combination(FDC)Drugs contains two or more active ingredients combined in a fixed-dose to form a single drug.

Example- a combination of Paracetamol with Ibuprofen.

Paracetamol is an analgesic (painkiller) and antipyretic (preventing fever), while Ibuprofen is a non-steroidal anti-inflammatory drug.

This combination cures the acute pain of many types like toothache, body ache etc.

Some  Fixed-Dose Combination(FDC)Drugs are marketed with licenses given only by “state regulatory agencies” rather than “Drug Controller General of India (DGCI).

Read the full article <a href=“https://diademy.com/fdc-fixed-dose-combination/”>Click here</a>

[purnomonissan]

New Normal, New Car. Pilih kendaraan yang cocok menemani Aktifitas MU. Promo terbaik New Normal bisa didapatkan disini Diskon s/d 100jt* DP Ringan * Bunga 0% * Tukar Tambah Mobil Lama* Cari tau lebih yuk... Call/WA : 087877970879 @purnomonissan #nissan #inibarucanggih #livina #serena #xtrail #terra #belanjadarirumah #dirumahaja #nissanid #promomurah #newnormal #jakarta #allnewlivina #allnewserena #allnewxtrail #gravinci #dgci #nlc #pilihankeluarga #idamankeluarga #mobil #jualmobil #dealermobil #otoamotif (di Jakarta, Indonesia) https://www.instagram.com/p/CBKE4xMFJ-O/?igshid=lbp8ihhb31ze

[nuoigadacuasat]

    Chẳng mấy chốc, người Ấn Độ sẽ có thể chìm răng vào gà Brazil     Bình luận

Ngày 28 tháng 4 năm 2019 | Ấn Độ

Sau khi chân gà đông lạnh từ Mỹ, các sản phẩm gia cầm từ xa Brazil đang trên đường tìm cách kích thích vị giác của người tiêu dùng Ấn Độ.

JBS, nhà chế biến thịt lớn nhất ở Brazil, chuẩn bị giới thiệu các sản phẩm thịt gà của mình, bao gồm cả đùi và chân, tại thị trường Ấn Độ thông qua công ty con Seara.

Tuần trước, Seara đã nhận được sự chấp thuận của chính quyền ở đây để bán sản phẩm gà của mình ở nước này.

Người chơi gia cầm trong nước đang loay hoay trước mối đe dọa mới nhất; nhập khẩu các sản phẩm gia cầm đã tăng trở lại trong năm 2018-19 sau khi Ấn Độ mất một tranh chấp kéo dài tại WTO với Mỹ.

Theo dữ liệu mới nhất của DGCIS (Tổng cục Tình báo và Thống kê Thương mại), nhập khẩu sản phẩm gia cầm đã tăng lên 797,73 tấn, trị giá 5,45 triệu USD ($37 crore) cho giai đoạn từ tháng 4 đến tháng 1 năm 2018-19. Trong năm tài chính trước đó, nhập khẩu gia cầm đứng ở mức 572 tấn, đạt 4,17 triệu USD ($26,87 crore).

Điều thú vị là nhập khẩu gia cầm từ Mỹ tăng mạnh nhất, ở mức 136,92 tấn trị giá 1,2 triệu USD, trong tháng 4-2018-19, so với 0,01 tấn trong năm trước.

" Trở lại

(function(d, s, id) { var js, fjs = d.getElementsByTagName(s)(0); if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "http://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.3&appId=538560492908899"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));(function(d, s, id) { var js, fjs = d.getElementsByTagName(s)(0); if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "http://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.4&appId=538560492908899"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Xem thêm tất cả chuyên mục tại https://nuoigadacuasat.com/category/tin-moi/gia-cam/

Bài viết     Chẳng mấy chốc, người Ấn Độ sẽ có thể chìm răng vào gà Brazil

    Bình luận đã xuất hiện đầu tiên vào ngày Nuôi Gà Đá Gà Cựa Sắt.

source https://nuoigadacuasat.com/chang-may-choc-nguoi-an-do-se-co-the-chim-rang-vao-ga-brazil-binh-luan/

[smestreet]

MSMEs Registered 49.81% Exports

As per the information from Directorate General of Commercial Intelligence & Statistics (DGCI&S), the share of export of specified MSME related Products in the All India Exports  each of the last 3 years  and current year is as follows:

S.No.      Year The percentage share of MSME products to total export1. 2019-20 (Upto Dec. 2019) 49.81 2. 2018-19 48.10 3. 2017-18 48.56 4. 2016-17 49.69

[aminalatif]

Fake cosmetics: Drug regulator notices to Amazon, other e-commerce sites for alleged sale of spurious cosmetics

NEW DELHI: Country’s drug regulator DCGI has issued notices to Amazon and some other e-commerce websites for allegedly selling “spurious, adulterated and unapproved” cosmetics, including imported brands, and has warned them of penal actions.

The notice from the Drug Controller General of India (DCGI) follows raids by drug inspectors at various locations across the country on October 5-6, during which they found that some indigenously manufactured cosmetics without valid manufacturing licence and having ingredients imported without necessary registration certificates were being sold on the e-commerce platforms.

The law provides for penal actions ranging from monetary fine to imprisonment for such lapses.

When contacted, an Amazon India spokesperson told PTI the company takes strict action against sellers of “illegal or fake products” as and when such incidents are reported to it.

“Amazon.in is a third-party marketplace which enables sellers to list their products for sale to Indian customers. Sellers on Amazon.in own their respective products and are responsible for product compliances, as may be applicable.

“Amazon.in has a very high bar of customer experience and does take strict action against sellers who are selling illegal or fake products us, in accordance with the due process of law, as and when such incidents are reported to us,” the spokesperson said.

According to a copy of the notice seen by PTI, the cosmetics being sold by these websites included imported brands without valid documents and containing ingredients in the “negative list” of the BIS (Bureau of Indian Standards).

Asking the companies to reply to its notice within 10 days, the DGCI has warned them of penal action for “offering for sale, sale and distribution of spurious, adulterated cosmetics and cosmetics manufactured without valid licence in contravention of the Drugs and Cosmetics Act, 1940.”

“In case, you fail to submit the reply within the stipulate period, it will be presumed that you have no reply to offer and appropriate action as deemed fit will be initiated against you,” DCGI S Eswara Reddy said in the notice.

Under the Drug and Cosmetics Act, it is mandatory to get a registration certificate for import of cosmetics into India, while all cosmetics manufactured in the country need to have a valid licence.

Besides, the cosmetics need to conform to the standards laid down by the Bureau of Indian Standards (BIS) and cannot have any ingredient mentioned in its negative list.

The post Fake cosmetics: Drug regulator notices to Amazon, other e-commerce sites for alleged sale of spurious cosmetics appeared first on Watch Online Pakistani Dramas.

from Watch Online Pakistani Dramas https://ift.tt/2q6jB53 via IFTTT

[iibmanswersheet-blog]

Why do we say UPS is an international logistics business, and general transport logistics Company

Need Answer Sheet of this Question paper, contact

aravind.banakar@gmail.com

www.mbacasestudyanswers.com ARAVIND – 09901366442 – 09902787224

 Export Import Management

 Multiple Choices:

Q1. In case of goods being rejected or wrong shipments which section of customer act provides drawback facility on the customer’s duty?

a. Section 47

b. Section 88

c. Section 74

d. Section 40

 Q2. Risks arising out of foreign law due to________________.

a. Lack of knowledge about foreign market

b. Expensive and complex litigation

c Both ‘a’ & ‘b’

d. None of the above

 Q3. Import LC is also known as ______________________.

a. Letter of Debt

b. Bills of exchange

c. Open account

d. Letter of credit

 Q4. How much digits are there in IEC number?

a. 8

b. 10

c. 12

d. 15

 Q5. What is the full form of RFID?

a. Rural Fund Information Development

b. Request For International Development

c. Radio Frequency Identification System

d. Radio Frequency Internal System

 Q6. The Export Inspection Council is a _____________________.

a. Support the export corporation

b. Responsible for the enforcement of QC

c. Administrative control of the ministry of Commerce & industry

d. Provides consultancy to export organization

 Q7. The World Trade Organization was formed in_________________.

a. 1994

b. 1995

c. 1996

d. 1997

 Q8. Government policies are related to__________________________.

a. Income tax

b. Sales tax

c. Both ‘a’ & ‘b’

d. None of the above

 Q9. Clearing and forwarding agents are an important link between_______________.

a. The exporter and various other agencies

b. The importer and various other agencies

c. Import and export of goods

d. All of the above

 Q10. Which Regional issues are important to commercial success?

a. Taxation matters

b. Importance of negotiations

c. Degree of market risk

d. All of the above

 Part Two:

Q1. Define EDI procedure.

Q2. Differentiation between “Measurement Rules” and “Pallet Rules”.

Q3. Explain the Benefits of Electronic Procurement.

Q4. What is DGCI$S?

 Q5. Define the role of intermediaries in Shipping Industry.

Q6. The public package meal companies implement service-time availability of difficulties, Explain.

Q7. The introduction of third-party logistics services to the public packet meals would you put forward any firm recommendations?

Q8. Why do we say UPS is an international logistics business, and general transport logistics Company?

Q9. To describe the international express logistics enterprises in the development prospects.

Q10. Discuss the role of Banks in an export-import transaction.

Q11. Describe briefly the steps involved in export business to succeed in the era of Globalization.

  Need Answer Sheet of this Question paper, contact

aravind.banakar@gmail.com

www.mbacasestudyanswers.com ARAVIND – 09901366442 – 09902787224